Business Wire

NY-EDELMAN

25.7.2022 13:07:11 CEST | Business Wire | Press release

Share
Edelman Launches Edelman Smithfield Globally to Focus on the Financial Markets and Strategic Situations

Edelman today announced the global launch of Edelman Smithfield, a financial communications boutique that specializes in the financial markets and strategic situations, serving clients in the United States, EMEA, Asia and beyond. The global launch brings together under one brand Edelman’s Financial Communications and Financial Services teams, combining specialized industry knowledge with global scale and localized expertise, while remaining connected to and integrated with Edelman’s full capabilities. Lex Suvanto will serve as Edelman Smithfield Global CEO.

Edelman Smithfield is focused on advising senior leaders and management teams navigating complex matters that impact reputation and valuation. The firm has deep expertise serving and communicating to the financial markets and is comprised of two primary practice areas:

  • Partnering with companies in the financial markets to help them protect, promote and evolve their reputation. Edelman Smithfield is a leading communications advisor in the financial markets, working with investment firms, private equity and venture capital funds, hedge funds, banks, insurers, fintech, crypto and other financial markets participants to develop and execute tailored communications programs that build trust and strengthen reputations in the marketplace.
  • Partnering with companies navigating and communicating with the financial markets and during strategic situations. Edelman Smithfield advises boards of directors, management teams and communications professionals on high impact strategic situations, such as mergers, acquisitions, IPOs, bankruptcies and restructurings, shareholder activism, litigation, management changes and regulatory matters, as well as ongoing engagement with the investment community, including investor relations and critical ESG matters.

Richard Edelman, CEO of Edelman, said, “The financial communications team has built an incredible platform and has advised on some of the highest profile clients and situations over the past several years. We continue to see significant demand from both existing and new clients for the work that they are leading, especially given the volatility and complexity of the global financial markets. There’s tremendous opportunity ahead, and we will continue to invest in Edelman Smithfield to ensure the team is well placed to define the next generation of financial communications.”

Edelman Smithfield is already a leading player in the financial communications industry. The firm’s asset management clients professionally manage more than $20 trillion combined, which, when coupled with insights from the annual Investor Trust survey, translates into a unique understanding of the global institutional investor landscape; Edelman Smithfield has advised on hundreds of transactions in the last five years, including some of the most prominent mergers and acquisitions, IPOs and restructurings.

Lex Suvanto, Global CEO of Edelman Smithfield, said, “We have a singular goal of building a financial communications powerhouse globally, and Edelman is providing the investment and runway to make this a reality. We are the only firm that specializes in the financial markets and strategic situations while bringing the reach and resources of broader Edelman. Together as a global team and with a unified banner and strategy, we will unlock new opportunities, while always prioritizing excellent client work, conducting ourselves with integrity and attracting and empowering an incredible team of dedicated advisors.”

Edelman Smithfield brings a strong leadership team with an impeccable track record of helping clients navigate the complex and dynamic financial markets. Global and regional leadership appointments include:

  • Lex Suvanto, Global CEO
  • John Kiely, Chairman of EMEA
  • Andrew Wilde, Global Head of Financial Services
  • Josh Hochberg, Global Chief Operating Officer
  • Katie Spring, President, United States
  • Alex Simmons, Head of EMEA
  • Jason Leow, Head of APAC

Edelman Smithfield also includes leaders and teams in a total of 25 cities and 15 countries around the world.

In 2015, Edelman acquired Smithfield, a UK-based financial communications firm, as part of its ongoing investment and growth in financial communications. Since that time, the Edelman Smithfield brand has been rolled out in Germany, the Middle East and Canada. Edelman plans to commit significant resources to the continued expansion of the Edelman Smithfield platform in key markets around the world.

About Edelman
Edelman is a global communications firm that partners with businesses and organizations to evolve, promote and protect their brands and reputations. Our 6,000 people in more than 60 offices deliver communications strategies that give our clients the confidence to lead and act with certainty, earning the trust of their stakeholders. Our honors include the Cannes Lions Grand Prix for PR; Advertising Age’s 2019 A-List; the Holmes Report’s 2018 Global Digital Agency of the Year; and, five times, Glassdoor’s Best Places to Work. Since our founding in 1952, we have remained an independent, family-run business. Edelman owns specialty companies Edelman Data x Intelligence (research, data) and United Entertainment Group (entertainment, sports, lifestyle).

About Edelman Smithfield
Edelman Smithfield is a financial communications boutique that specializes in the financial markets and strategic situations with the full reach and resources of Edelman. The Edelman Smithfield team comprises approximately 250 advisors across more than 25 cities and 15 countries serving an expansive roster of top organizations around the world. www.EdelmanSmithfield.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye